Noscapine may increase the effect of warfarin [4]

British Journal of Clinical Pharmacology

Volumn 65, Issue 2, 2008, Pages 277-278

  Ohlsson, Staffan ^a   Holm, Lennart ^a   Myrberg, Olle ^b   Sundström, Anders ^a   Yue, Qun Ying ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITUSSIVE AGENT; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; NON PRESCRIPTION DRUG; NOSCAPINE; PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN;

BLEEDING; BODY WEIGHT; CONFIDENCE INTERVAL; COUGHING; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INFORMATION; DRUG INHIBITION; DRUG METABOLISM; DRUG WITHDRAWAL; HUMAN; IC 50; INTERNATIONAL NORMALIZED RATIO; LETTER; MEDICAL LITERATURE; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DRUG SYNERGISM; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; NOSCAPINE; WARFARIN;

EID: 38849140372     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03018.x     Document Type: Letter

References (5)

1. Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet 2007 121 : 23 34.
2. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2004 57 : 127 34.
3. Karlsson MO, Dahlström B, Eckernäs S-Å, Johansson M, Tufvesson Alm A. Pharmacokinetics of oral noscapine. Eur J Clin Pharmacol 1990 39 : 275 9.
4. Aneja R, Katyal A, Chandra R. Modulatory influence of noscapine on the ethanol-altered hepatic biotransformation system enzymes, glutathione content and lipid peroxidation in vivo in rats. Eur J Drug Metab Pharmacokinet 2004 29 : 157 62.
5. Renton KW. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 2001 92 : 147 63.